Orlando, Florida – October 7, 2011 Cardiac Rehab: Improving Outcomes One Step at a Time Martha Gulati MD, MS, FACC, FAHA Associate Professor of Medicine.

Slides:



Advertisements
Similar presentations
Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
Advertisements

Ranexa™ for Chronic Angina An Unmet Need
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
EXERCISE PRESCRIPTIONS FOR CARDIAC PATIENTS To offset physiological and psychological effects of bed rest Medical surveillance of patients Identify patients.
Benefits and Risks Associated with Exercise and Exercise Testing.
Research with clinical populations: Cardiac rehabilitation Shawn N Fraser University of Alberta.
Benefits of Cardiac Rehabilitation: Impact on Mortality, Hospitalizations and Risk Factors Reggie Higashi, MSS Exercise Physiologist.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation? July
Arthur Stillman, M.D., Ph.D., PI Pamela Woodard, M.D., Study Co-chair Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Healthy People 2010 Focus Area 12: Heart Disease and Stroke Progress Review May 21, 2007.
CLOSE TO YOUR HEART  By Becky Blaauw  Biokineticist.
Cardiac rehabilitation (CR) uses a multidisciplinary approach and provides a secondary prevention through risk factor identification and modification in.
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
Cardiac Rehabilitation Presented By: Dr. Ramesh Tharwani Consultant Cardiologist Choithram Hospital.
New guidelines for CABG
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
19 Prescription of Exercise for Health and Fitness chapter.
Redefining Treatment Strategies for Optimal Medical Care in CAD COURAGE and MERLIN-TIMI 36.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stan Schwartz MD,FACP.
Secondary Prevention & Cardiac Rehabilitation Malcolm Walker Consultant Cardiologist UCLH & the Heart Hospital, London.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
Depressive Disorders and Cardiovascular Medicine Lawson Wulsin, MD Copyright © World Psychiatric Association.
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 12 Resistance-Training Strategies for Individuals with Coronary Heart Disease.
Cardiac Rehabilitation Benefits of cardiac rehabilitation: Improve quality of life. Decrease risk fetal heart attack. Decrease severity of angina Decrease.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Atypical Presentations Patients older than 75: frequently no chest pain ECG in evolution (nonspecific ECG changes) Diabetic patients: commonly no chest.
Contemporary Management of Myocardial Ischemia
Medical Management of Claudication: Just Walk it Off!!
Exercise Management Chronic Heart Failure Chapter 12.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
HEART ATTACK By: Claudia Forte and Raquel Pimentel.
Chapter Exercise and Heart Disease David R. Bassett Jr. C H A P T E R.
Risk Factor Modification in CCR. How does CR work?
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Women reaching equality in health, despite the differences Nowadays women remain the largest CAD population subgroup being under-diagnosed and under-treated.
Women and Cardiovascular Disease
Cardiac Rehabilitation Part I
Heart Transplantation
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Hypertension in the Post SPRINT era
Revascularization in Patients With Left Ventricular Dysfunction:
Complex Coronary intervention
Clinical need for determination of vulnerable plaques
Cardiac rehabilitation phase II
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Section I: RAS manipulation C. Update on clinical trials in CAD
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
O.L.Reuchlin gebruik van CT binnen de cardiogie
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Cardiac Rehab Riya Pulicharam, MD National Medical Director,
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Orlando, Florida – October 7, 2011 Cardiac Rehab: Improving Outcomes One Step at a Time Martha Gulati MD, MS, FACC, FAHA Associate Professor of Medicine (Cardiology) Associate Professor of Clinical Public Health (Epidemiology) Sarah Ross Soter Chair in Women’s Cardiovascular Health Director for Women’s Cardiovascular Health and Preventive Cardiology The Ohio State University, Columbus, OH

Exercise for 2° CHD Prevention: Who? 2  Eligibility for Cardiac Rehabilitation  Post MI, ACS  Post CABG  Post PCI  Post Valve Repair/Replacement  Stable Angina  Heart Transplant  Medicare was considering Advanced Heart Failure but to date, no coverage

Exercise for 2° CHD Prevention: Why? 3  Proven Benefit  Reduction in All-Cause Mortality by 20-32%  Reduction in Sudden Cardiac Death by 37%  Reduction in Fatal Recurrent MI by 22%  19% Reduction in Mortality in those attending 2/3 of sessions Lavie et al Mayo Clinic Proc 2009;84:

Exercise for 2° CHD Prevention: Why? 4  Proven Risk Factor Modification  Risk Factor Reduction:  Total Cholesterol (-14.3 mg/dL CI – -4.2)  Systolic Blood Pressure (-3.2 mm Hg: -5.4 – -0.9)  Increased Smoking Cessation  40-70% reduction in Depression, Anxiety and Hostility,  Regular Exercise, Healthier Diet Taylor et al. AM J Med 2004; 110 Lavie et al Am J Cardiol;2004:93 Lavie et al. Mayo Clinic Proc 2006:80

Exercise for 2° CHD Prevention: Why? 5  Improved functional capacity  Improved CAD risk factor control  Reduced depression  Improved survival  Though originally designed for coronary artery disease patients, there is accumulating evidence that patients with other cardiac diseases will also benefit from cardiac rehabilitation

Women and Cardiac Rehabilitation 6  Paucity of research on Women and Cardiac Rehabilitation  In meta-analysis, 54% of studies included women, but women made up only 20% of all participants  Only 25% of women eligible for cardiac rehabilitation are referred to cardiac rehabilitation  Of the 25% referred, only 50% enroll  Of those enrolled, only 15% complete a 12-week program (women and smokers less likely to complete)  African American Women less likely to be referred, attend and complete Cardiac Rehab than white women Taylor et al. Am J Med 2004; 110 Benz-Scott et al. J Women Health 2002;11:773-91

Cardiac Rehabilitation 2011  Doesn’t everyone already go to cardiac rehabilitation?  Cardiac rehabilitation programs remain underused in the United States, with an estimated participation rate of only 10-20% of the >2 million eligible patients/year who experience an AMI or undergo coronary revascularization  Rates of % for men and % for women reported in various regional and national surveys  Highest rates post-CABG  Lowest rates after elective PCI Ades PA. N Engl J Med. 2001; 345: 892–902

8 Cardiac rehabilitation can significantly improve the life expectancy and quality of life of people who have had a recent cardiac event, such as a heart attack, angioplasty or heart surgery.

9

Exercise considerations for the angina patient  Goal: increase anginal and ischemic threshold  Prolonged warm-up & cool down (gradual rise)  Target HR below ischmic level (± 10 bpm)  Caution with exertion in the cold  Upper body exercise may precipitate symptoms due to higher pressor response  NTG  Monitor blood pressures before and after exercise (or NTG use)  Alternative exercise: frequent, short, intermittent sessions

Exercise considerations for the CHF patient  Must be on stable medical therapy  Monitor hypokalemia and hemodynamic response  Malignant dysrhythmia  THR 40-70% VO2max 3-7days per week, minutes per session  Long warm-up and cool down  Interval exercise training  RPE may be used

Exercise considerations for the cardiac transplant patient  1-3 year survival rates of 86% and 80%  Train wreck physically and metabolically  Rx from data from testing, graded protocols  Long warm up & cool down  Denervated heart = no angina, low EKG sensitivity for ischemia, delayed cardioacceleratory (and deceleratory) response  Stress echo or radionuclide testing  Intensity:  50-75% of VO2peak  RPE of on the 6-20 scale  Dyspnea

Exercise considerations for the pacemaker/ICD patient  Fixed vs. adjustable rate  Monitor systolic pressures  Extended warm-up and cool down  ICD: ECG monitoring/pulse to titrate intensity  Rate modulated pacemakers intensity:  MHRR method of Karvonen  Fixed percentage of MHR  RPE  METs